Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.00 | -15.27 |
| PEG Ratio (TTM) | N/A | -4.35 |
| P/S Ratio (TTM) | 315.90 | 45.97 |
| P/B Ratio (TTM) | 0.68 | 28.96 |
| P/FCF Ratio (TTM) | 0.00 | -2.59 |
| Price to 5YR AVG Earnings Ratio | N/A | -5.56 |
| Price to 5YR AVG FCF Ratio | N/A | -12.33 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -23,587.96% | -19.06% |
| ROE (TTM) | -26,438.24% | 15.70% |
| Net Profit Margin (TTM) | -12,414,736.82% | -813.88% |
| ROIC 5YR AVG | N/A | 3.12% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -18,757.97% | -0.50% | N/A |
| Revenue | -68.39% | 160.81% | N/A |
| Net Income | -19,491.27% | -38.20% | N/A |
| Cash Flow | -74,728.33% | -34.44% | N/A |
Health (18%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.88 | 5.56 |
| Quick Ratio (TTM) | 0.20 | 5.34 |
| D/E Ratio (TTM) | 169.23 | 0.95 |
| Interest Coverage (TTM) | -259.53 | -6.44 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | N/A | 12.45 |
| LTL to 5YR AVG FCF | N/A | 0.11 |
| Shares Outstanding Growth 5YR AVG | N/A | 37.46% |